Marrocco, Ilaria
 Distribuzione geografica
Continente #
AS - Asia 806
NA - Nord America 635
EU - Europa 305
SA - Sud America 199
AF - Africa 25
AN - Antartide 1
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 1.973
Nazione #
US - Stati Uniti d'America 605
SG - Singapore 329
CN - Cina 226
BR - Brasile 165
IT - Italia 92
VN - Vietnam 76
IN - India 51
IE - Irlanda 37
FR - Francia 36
DE - Germania 35
FI - Finlandia 26
ID - Indonesia 25
KR - Corea 19
HK - Hong Kong 18
RU - Federazione Russa 17
SE - Svezia 17
AR - Argentina 16
BD - Bangladesh 15
CA - Canada 14
JP - Giappone 14
GB - Regno Unito 10
IQ - Iraq 8
NL - Olanda 7
ZA - Sudafrica 7
AT - Austria 6
DZ - Algeria 6
EC - Ecuador 6
PK - Pakistan 6
CL - Cile 5
ES - Italia 4
JM - Giamaica 4
MX - Messico 4
PL - Polonia 4
UA - Ucraina 4
AZ - Azerbaigian 3
CO - Colombia 3
CZ - Repubblica Ceca 3
EG - Egitto 3
SN - Senegal 3
TR - Turchia 3
AE - Emirati Arabi Uniti 2
BA - Bosnia-Erzegovina 2
CR - Costa Rica 2
JO - Giordania 2
KE - Kenya 2
LT - Lituania 2
PY - Paraguay 2
SA - Arabia Saudita 2
TW - Taiwan 2
AO - Angola 1
AQ - Antartide 1
BB - Barbados 1
BO - Bolivia 1
BS - Bahamas 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CW - ???statistics.table.value.countryCode.CW??? 1
DM - Dominica 1
EE - Estonia 1
KZ - Kazakistan 1
LB - Libano 1
MM - Myanmar 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
PG - Papua Nuova Guinea 1
SV - El Salvador 1
TN - Tunisia 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 1.973
Città #
Singapore 167
Ashburn 102
San Jose 84
Hefei 58
Beijing 38
Dublin 37
Milan 27
Jakarta 24
Helsinki 22
Lauterbourg 21
Pune 21
Council Bluffs 20
Ho Chi Minh City 20
Frankfurt am Main 19
Seoul 19
Hanoi 18
New York 18
Rome 18
Hyderabad 17
Hong Kong 16
Los Angeles 16
Dallas 14
Kent 14
Moscow 13
São Paulo 13
Tokyo 13
Phoenix 9
Chicago 8
Santa Clara 8
Bologna 7
Boardman 6
Nuremberg 6
Dhaka 5
Haiphong 5
North Bergen 5
Paris 5
Rio de Janeiro 5
Baghdad 4
Belo Horizonte 4
Brescia 4
Brooklyn 4
Da Nang 4
Falkenstein 4
Halle 4
Johannesburg 4
Kingston 4
Lappeenranta 4
Porto Alegre 4
Vienna 4
Baku 3
Blumenau 3
Brampton 3
Brno 3
Busto Arsizio 3
Charlotte 3
Dakar 3
Elk Grove Village 3
Juiz de Fora 3
Quito 3
Seattle 3
Stockholm 3
Amman 2
Arese 2
Atibaia 2
Atlanta 2
Bexley 2
Blida 2
Boston 2
Bắc Ninh 2
Campinas 2
Changsha 2
Chennai 2
Chlef 2
Curitiba 2
Denver 2
Dubai 2
Durban 2
Edmonton 2
Erba 2
Fortaleza 2
Guayaquil 2
Hải Dương 2
Jaboatão dos Guararapes 2
Joinville 2
Kaunas 2
Lanús 2
Limeira 2
London 2
Maricá 2
Mexico City 2
Mumbai 2
Nairobi 2
Ninh Bình 2
Nova Iguaçu 2
Phủ Lý 2
Pindamonhangaba 2
Pittsburgh 2
Posadas 2
Quảng Ngãi 2
Raleigh 2
Totale 1.080
Nome #
L858R emerges as a potential biomarker predicting response of lung cancer models to anti-EGFR antibodies: Comparison of osimertinib vs. cetuximab 129
A bispecific antibody targeting EGFR and AXL delays resistance to osimertinib 124
Shmt2: A Stat3 signaling new player in prostate cancer energy metabolism 114
Resistance of Lung Cancer to EGFR-Specific Kinase Inhibitors: Activation of Bypass Pathways and Endogenous Mutators 98
A combination of approved antibodies overcomes resistance of lung cancer to osimertinib by blocking bypass pathways 97
Egfr in cancer: Signaling mechanisms, drugs and acquired resistance 90
Clustering of IRE1α depends on sensing ER stress but not on its RNase activity 89
Strategies to Overcome Resistance to Osimertinib in EGFR-Mutated Lung Cancer 84
Host-dependent phenotypic resistance to EGFR tyrosine kinase inhibitors 84
TSHZ2 is an EGF-regulated tumor suppressor that binds to the cytokinesis regulator PRC1 and inhibits metastasis 81
ETS Proteins Bind with Glucocorticoid Receptors: Relevance for Treatment of Ewing Sarcoma 80
An interdomain helix in IRE1α mediates the conformational change required for the sensor's activation 78
Targeting her3, a catalytically defective receptor tyrosine kinase, prevents resistance of lung cancer to a third-generation egfr kinase inhibitor 78
Upfront admixing antibodies and EGFR inhibitors preempts sequential treatments in lung cancer models 76
Inhibition of a pancreatic cancer model by cooperative pairs of clinically approved and experimental antibodies 74
An oligoclonal antibody durably overcomes resistance of lung cancer to third-generation EGFR inhibitors 71
Cancer Immunotherapy: The Dawn of Antibody Cocktails 71
Roles for growth factors and mutations in metastatic dissemination 70
ERp57 chaperon protein protects neuronal cells from Aβ-induced toxicity 68
Punicalagin, an active pomegranate component, is a new inhibitor of PDIA3 reductase activity 67
Roles for receptor tyrosine kinases in tumor progression and implications for cancer treatment 65
Increased intake of energy-dense diet and negative energy balance in a mouse model of chronic psychosocial defeat 63
Comparative analysis of the interaction between different flavonoids and PDIA3 58
Analysis of STAT3 post-translational modifications (PTMs) in human prostate cancer with different Gleason Score 52
Measurement and Clinical Significance of Biomarkers of Oxidative Stress in Humans 46
Totale 2.007
Categoria #
all - tutte 10.225
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.225


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202345 0 0 0 0 0 0 0 0 25 16 4 0
2023/2024226 2 44 0 34 10 43 11 3 1 9 33 36
2024/2025465 9 1 26 26 18 26 9 14 56 46 163 71
2025/20261.253 181 60 77 90 183 52 196 209 72 58 32 43
2026/202718 18 0 0 0 0 0 0 0 0 0 0 0
Totale 2.007